Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse

Biological Research

Volumn 35, Issue 3-4, 2002, Pages 339-345

  Illanes, Julio ^a   Dabancens, Alfredo ^b   Acuña, Olga ^b   Fuenzalida, Marcela ^a   Guerrero, Anibal ^a   Lopez, Claudia ^b   Lemus, David ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ATROPINE; BETAMETHASONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIAZEPAM; GLUCOCORTICOID RECEPTOR; ISOENZYME; KETAMINE; MEPACRINE; NUCLEAR PROTEIN; POLYURETHAN; PROSTAGLANDIN; STEROID; SULINDAC; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, MOUSE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN LOCALIZATION; RAT; REVIEW; STROMA CELL; ANIMAL; APOPTOSIS; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; FEMALE; MOUSE; PATHOLOGY; SURGICAL SPONGE;

ANIMALIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BETAMETHASONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUG THERAPY, COMBINATION; FEMALE; ISOENZYMES; MEMBRANE PROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; POLYURETHANES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUINACRINE; SULINDAC; SURGICAL SPONGES;

EID: 0036440658     PISSN: 07169760     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-97602002000300008     Document Type: Review

References (29)

1. BAMBERGER CM, BAMBERGER AM, DE CASTRO M, CHROUSOS GP (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95: 2435-2441
2. BOUCK N, STELLMACH V, HSU SC (1996) How tumors become angiogenic. Adv Cancer Res 69, 135-174
3. BOYLE EA, MANGAN FR (1982) The effect a novel, non-steroidal anti-inflammatory compound, nabumetone (BRL14777), on cellular infiltration into 24-hour polyvinyl sponge implants in the rat, compared with some steroidal and non-steroidal anti-inflammatory drugs. J Pharm Pharmacol 34: 570-575
4. BUTTGEREIT F, WEHLING M, BURMESTER GR (1998) A new hypothesis of modular glucocorticoid actions. Arthritis & Rheumatism 41: 761-767
5. CARMELIET P (2000) Mechanisms of angiogenesis and arteriogenesis. Nature Med 6: 389-395
6. 2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expresion in cultured rat Muller cells. Invest Ophthalmol Vis 39: 581-591
7. 2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase. Biochem Pharmacol 55: 105-111
8. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59: 4574-4577
9. FUKUMURA D, XAVIER R, SUGIURA T, CHEN Y, PARK EC, LU N (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725
10. GAVRIELI Y, SHERMAN Y, BEN-SASSON S (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
11. 2 enzymes: Selective inhibitors and their pharmacological potential. Adv Pharmacol 32: 31-66
12. GOULDING NJ, GUYRE PM (1993) Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 5: 108-113
13. HANAHAN D, WEINBERG RA (2000) The hallmarks of cancer. Cell 100: 57-70
14. HOPER M, VOELKEL NF, BATES TO, ALLARD JD, HORAN M, SHEPHERD D (1997) Prostaglandins induce vascular endothelial growth factor in human monocytic cell line and rat lungs via AMP. Am J Respir Cell Mol Biol 17: 748-756
15. LAPETINA EG, BILLAN MM, CUATROCASAS P (1981) Thephosphatidylinositol cycle and the regulation of arachidonic acid production. Nature 292:367-369
16. LEMUS D, DABANCENS A, ILLANES J, FUENZALIDA M, GUERRERO A, LOPEZ C (2001) Antiangiogenic effect of betamethasone on the chick CAM stimulated by TA3 tumor supernatant. Biol Res 34: 227-236
17. LEVY GN (1997) Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs and colon cancer. FASEB J 11: 234-247
18. MALONNE H, LANGER J, KISS R, ATASSI G (1999) Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors. Clinical and Experimental Metastasis 17: 1-14
19. MOORE FL, ORCHINIK M (1994) Membrane receptors for corticosterone: a mechanism for rapid behavioural responses in an amphibian. Horm Behav 28: 512-519
20. MOSCATELLI D, GROSS JL, RIFKIN DB (1981) Angiogenic factors stimulate plasminogen activator and collagenase production by capillary endothelial cells (abstract). J Cell Biol 91: 201a
21. NAGY JA, BROWN LF, SENGER DR, LANIR N, VAN DE WATER L, DVORAK AM, DVORAK HF (1989) Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948: 305-326
22. NEEDLEMAN P, TURK J, JAKSCHIK BA, MORRISON AR, LEFKOWITH JB (1986) Arachidonic acid metabolism. Annu Rev Biochem 55: 69-102
23. PIETRAS RJ, SZEGO CM (1975) Endometrial Cell calcium and oestrogen action. Nature 253: 357-359
24. REED J (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941-53
25. RICE PL, GOLDBERG RJ, RAY EC, DRIGGERS LJ, AHNEN DJ (2001) Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res 61 (4): 1541-1547
26. SOH JW, MAO Y, KIM MG, PAMUKCU R, LI H, PIAZZA GA, THOMPSON WJ, WEINSTEIN IB (2000) Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin Cancer Res 6 (10): 4136-4141
27. TAMM I, SCHRIEVER F, DORKEN B (2000) Apoptosis: implications of basic research for clinical oncology. Lancet Oncol 2: 33-42
28. YAMADA M, KAWAI M, KAWAI Y, MASHIMA Y (1999) The effect of selective cyclooxygenase-2-inhibitor on corneal angiogenesis in the rat. Curr Eye Res, 19: 300-304
29. WILLIAMS CS, TSUJII M, REESE J, DEY SK, DUBOIS RN (2000) Host cycloxygenase-2 modulates carcinoma growth. J Clin Invest 105: 1589-1594